Genetic Technologies Ltd GNTLF:Grey Market

RT Quote | Exchange | USD
Last | 04/08/21 EDT
0.011UNCH (UNCH)
52 week range
0.00 - 0.01

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.011
  • 52 Week High0.01
  • 52 Week High Date04/07/21
  • 52 Week Low0.00
  • 52 Week Low Date12/16/20

Key Stats

  • Market Cap251.71M
  • Shares Out55.08M
  • 10 Day Average Volume25,275
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.011
  • 52 Week High0.01
  • 52 Week High Date04/07/21
  • 52 Week Low0.00
  • 52 Week Low Date12/16/20
  • Market Cap251.71M
  • Shares Out55.08M
  • 10 Day Average Volume25,275
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-12.88
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Genetic Technologies Ltd

There is no recent news for this security.

Profile

MORE
Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well...
Peter Rubenstein
Chairman
Simon Morriss
Chief Executive Officer
Stan Sack
Chief Operating Officer
Phillip Hains
Chief Financial Officer
Address
60-66 Hanover St, Fitzroy
Melbourne, VIC
3065
Australia